About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

5.085 +0.125 (+2.52%)
Streaming Delayed Price Updated: 2:15 PM EDT, Jun 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 687,400
Open 4.960
Bid (Size) 5.080 (4,300)
Ask (Size) 5.090 (3,200)
Prev. Close 4.960
Today's Range 4.920 - 5.140
52wk Range 1.990 - 5.300
Shares Outstanding 112,280,375
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
From Maravai LifeSciences
Via Business Wire
News headline image
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
From Maravai LifeSciences Holdings, Inc.
Via Business Wire

Performance

YTD
+49.6%
+49.6%
1 Month
+24.6%
+24.6%
3 Month
+61.4%
+61.4%
6 Month
+38.6%
+38.6%
1 Year
+135.4%
+135.4%

More News

Read More
News headline image
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai (MRVI) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Maravai LifeSciences (NASDAQ:MRVI) Surges After Crushing Q1 Estimates and Raising Full-Year Guidance ↗
Via Chartmill
Maravai Lifesciences (NASDAQ:MRVI) Returns to Positive Adjusted EBITDA and Issues 2026 Guidance ↗
Via Chartmill
News headline image
Maravai LifeSciences Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
Maravai LifeSciences Reports First Quarter 2026 Financial Results
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
Top movers in Wednesday's after hours session ↗
Via Chartmill
News headline image
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Teleflex Stock Slides 39% in a Year, but This $8.5 Million Buy Signals a Contrarian Bet ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About a New $9 Million Bet on an Energy Distributor Stock ↗
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
This Biopharma Stock Has Surged Nearly 100% and One Fund Just Locked in Gains With a $10 Million Exit ↗
Via The Motley Fool
News headline image
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance ↗
Via Chartmill
News headline image
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire

Frequently Asked Questions

Is Maravai LifeSciences Holdings, Inc. - Class A common stock publicly traded?
Yes, Maravai LifeSciences Holdings, Inc. - Class A common stock is publicly traded.
What exchange does Maravai LifeSciences Holdings, Inc. - Class A common stock trade on?
Maravai LifeSciences Holdings, Inc. - Class A common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock?
The ticker symbol for Maravai LifeSciences Holdings, Inc. - Class A common stock is MRVI on the Nasdaq Stock Market
What is the current price of Maravai LifeSciences Holdings, Inc. - Class A common stock?
The current price of Maravai LifeSciences Holdings, Inc. - Class A common stock is 5.085
When was Maravai LifeSciences Holdings, Inc. - Class A common stock last traded?
The last trade of Maravai LifeSciences Holdings, Inc. - Class A common stock was at 06/16/26 02:15 PM ET
What is the market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock?
The market capitalization of Maravai LifeSciences Holdings, Inc. - Class A common stock is 570.95M
How many shares of Maravai LifeSciences Holdings, Inc. - Class A common stock are outstanding?
Maravai LifeSciences Holdings, Inc. - Class A common stock has 571M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.